Zobrazeno 1 - 10
of 21
pro vyhledávání: '"David J. Zammit"'
Autor:
Sandeep Gupta, Louis J. Denis, Niranjan S. Rao, Mahesh Mistry, Jun-Hsiang Lin, Sanjeeva P. Reddy, Helen Usansky, Nitin K. Damle, David J. Zammit, Roger A. Smith
Supplementary Data and Figures S1 to S6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0db6e8841fe5e495429a08a8f375ce73
https://doi.org/10.1158/1535-7163.22522731.v1
https://doi.org/10.1158/1535-7163.22522731.v1
Autor:
Pablo A. Jimenez, Howard L. Sofen, Robert Bissonnette, Mark Lee, Joseph Fowler, David J. Zammit, Yusong Chen, Niranjan Rao, Louis Denis, Sandeep Gupta
Publikováno v:
Journal of the American Academy of Dermatology.
Autor:
Sandeep Gupta, David J. Zammit, Helen Usansky, Mahesh Mistry, L. Denis, Niranjan Rao, Jun-Hsiang Lin, Sanjeeva Reddy, Roger Astbury Smith, Nitin K Damle
Publikováno v:
Molecular cancer therapeutics. 20(8)
The 5T4 oncofetal antigen (trophoblast glycoprotein) is expressed in a wide range of malignant tumors but shows very limited expression in normal adult tissues. ASN004 is a 5T4-targeted antibody–drug conjugate (ADC) that incorporates a novel single
Autor:
Niranjan Rao, N. Bhatia, L. Denis, M. Zook, M. Lee, Howard Sofen, T. Song, David M. Pariser, Helen Usansky, Seth B Forman, S. Dhawan, E. Guttman-Yassky, Robert Bissonnette, Ana B. Pavel, S. K. Tyring, Joseph F. Fowler, Catherine Maari, David J. Zammit
Publikováno v:
British Journal of Dermatology. 181
Autor:
M. Lee, Howard Sofen, Robert Bissonnette, S. Dhawan, T. Song, M. Zook, Helen Usansky, C. Maari, S. K. Tyring, Ana B. Pavel, Joseph F. Fowler, S. Forman, David M. Pariser, David J. Zammit, E. Guttman-Yassky, L. Denis, Niranjan Rao, N. Bhatia
Publikováno v:
British Journal of Dermatology. 181
Autor:
Yeriel Estrada, Emma Guttman-Yassky, James G. Krueger, Ning Zhang, Ana B. Pavel, Hui Xu, Celina Dubin, Xiangyu Peng, Hyun Je Kim, David J. Zammit, T. Song, Niranjan Rao, L. Denis, Sandeep Gupta, Robert Bissonnette, Ester Del Duca
Publikováno v:
The Journal of allergy and clinical immunology. 144(4)
Background Moderate-to-severe atopic dermatitis (AD) has been associated with significant disease burden and systemic abnormalities and often requires systemic treatments. Currently, safe and effective oral systemic treatments for moderate-to-severe
Autor:
S. Dhawan, M. Zook, David J. Zammit, M. Lee, Howard Sofen, Niranjan Rao, N. Bhatia, Emma Guttman-Yassky, Catherine Maari, Helen Usansky, L. Denis, Joseph F. Fowler, S. Tyring, Robert Bissonnette, T. Song, S. Forman, David M. Pariser, Ana B. Pavel
Publikováno v:
The British Journal of Dermatology
Summary Background ASN002 is an oral dual inhibitor of Janus kinase and spleen tyrosine kinase, which are involved in the pathogenesis of atopic dermatitis (AD) through their regulatory role on T helper (Th)1, Th2 and Th17/Th22 pathways. Objectives T
Publikováno v:
Journal of Investigative Dermatology. 138:S95
Publikováno v:
Molecular Cancer Therapeutics. 17:B109-B109
The 5T4 oncofetal antigen (trophoblast glycoprotein) is expressed in a wide range of malignant tumors, while showing very limited expression in normal adult tissues. This selective pattern of expression establishes 5T4 as an attractive therapeutic ta
Autor:
Aaron M. Slaiby, Marianne A. Mihalyo, Adam J. Adler, Harry Z. Qui, Leo Lefrançois, David J. Zammit, Adam T. Hagymasi
Publikováno v:
The Journal of Immunology. 179:1524-1531
Bone marrow-derived APC are critical for both priming effector/memory T cell responses to pathogens and inducing peripheral tolerance in self-reactive T cells. In particular, dendritic cells (DC) can acquire peripheral self-Ags under steady state con